Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun;46(2):173-185.
doi: 10.1016/j.clp.2019.02.002. Epub 2019 Mar 30.

Treatment and Prevention of Hypertensive Disorders During Pregnancy

Affiliations
Review

Treatment and Prevention of Hypertensive Disorders During Pregnancy

Karla Leavitt et al. Clin Perinatol. 2019 Jun.

Abstract

This article reviews the pharmacology of the most commonly used antihypertensive medications during pregnancy; their mechanism of action; and the effects on the mother, the fetus, and lactation. Each class of antihypertensive pharmacologic agents have specific mechanisms of action by which they exert their antihypertensive effect. β-Adrenoreceptor antagonists block these receptors in the peripheral circulation. Calcium channel blockers result in arterial vasodilation. α-Agonists inhibit vasoconstriction. Methyldopa is a centrally acting adrenoreceptor antagonist. Vasodilators have a direct effect on vascular smooth muscle. Diuretics decrease intravascular volume. Medications acting on the angiotensin pathway are avoided during pregnancy because of fetotoxic effects.

Keywords: Hypertension during pregnancy; Hypertension medications during pregnancy; Hypertensive disorders during pregnancy; Hypertensive disorders of pregnancy; Maternal hypertension; Pharmacologic therapy of hypertension during pregnancy; Treatment of hypertension during pregnancy.

PubMed Disclaimer

MeSH terms